Please see below to view details for this session presenter

Paul Lammers, MD

President and Chief Executive Officer, Mirna Therapeutics

Dr. Lammers joined Mirna Therapeutics in November 2009 as its President, CEO, and Director of the Board. Prior to joining Mirna Therapeutics, Dr. Lammers was most recently President of Repros Therapeutics. Dr. Lammers served for 6 years as the Chief Medical Officer for EMD Serono Inc., a Division of Merck KgA, leading a clinical development, medical and regulatory team of 150 people, and began his career with Organon spending 8 years in the commercial and clinical operations in Europe and the US. He also served 4 years as Senior Vice President of clinical and regulatory affairs at Zonagen in The Woodlands, TX.  Dr. Lammers obtained his Medical and Masters of Science degrees from Radboud University in Nijmegen, The Netherlands, and moved to the US in 1992.